# A 52-week Clinical Investigation of Princess® VOLUME PLUS Lidocaine in Subjects With Midface Volume Deficit

> **NCT03532126** · — · COMPLETED · sponsor: **Croma-Pharma GmbH** · enrollment: 91 (actual)

## Conditions studied

- Midface Volume Deficit

## Interventions

- **DEVICE:** Dermal filler for midface deficit

## Key facts

- **NCT ID:** NCT03532126
- **Lead sponsor:** Croma-Pharma GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-03-28
- **Primary completion:** 2019-07-24
- **Final completion:** 2020-06-30
- **Target enrollment:** 91 (ACTUAL)
- **Last updated:** 2024-12-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03532126

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03532126, "A 52-week Clinical Investigation of Princess® VOLUME PLUS Lidocaine in Subjects With Midface Volume Deficit". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT03532126. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*